Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion, |
RCV002052135 | SCV002318619 | pathogenic | Arthrogryposis, renal dysfunction, and cholestasis 1 | 2022-03-22 | criteria provided, single submitter | clinical testing | Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. It is not observed in the gnomAD v2.1.1 dataset. This variant has been reported to be associated with VPS33B related disorder (PMID:18853461). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |
OMIM | RCV002052135 | SCV002564412 | pathogenic | Arthrogryposis, renal dysfunction, and cholestasis 1 | 2022-08-18 | no assertion criteria provided | literature only | |
OMIM | RCV002276993 | SCV002564418 | pathogenic | Cholestasis, progressive familial intrahepatic, 12 | 2022-08-18 | no assertion criteria provided | literature only |